Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Flavia Morales"'
Autor:
Sherko Kuemmel, Catherine Harper-Wynne, Yeon Hee Park, Fábio Franke, Michelino de Laurentiis, Eva Schumacher-Wulf, Daniel Eiger, Sarah Heeson, Andrés Cardona, Özgür Özyilkan, Flavia Morales-Vàsquez, Ciara Metcalfe, Marc Hafner, Eleonora Restuccia, Joyce O’Shaughnessy
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background HER2-positive, estrogen receptor-positive breast cancer (HER2+, ER+ BC) is a distinct disease subtype associated with inferior response to chemotherapy plus HER2-targeted therapy compared with HER2+, ER-negative BC. Bi-directional
Externí odkaz:
https://doaj.org/article/e5f45a7c5b7e4bb7bb99b0bb30af3b2c
Autor:
Enrique Pedernera, Flavia Morales-Vásquez, María J Gómora, Miguel A Almaraz, Esteban Mena, Delia Pérez-Montiel, Elizabeth Rendon, Horacio López-Basave, Juan Maldonado-Cubas, Carmen Méndez
Publikováno v:
Endocrine Connections, Vol 12, Iss 12, Pp 1-9 (2023)
The incidence of ovarian cancer has been epidemiologically related to female reproductive events and hormone replacement therapy after menopause. This highlights the importance of evaluating the role of sexual steroid hormones in ovarian cancer by th
Externí odkaz:
https://doaj.org/article/49644390e91e4a55a7840b45571824d0
Autor:
Horacio N. López-Basave, Flavia Morales-Vázquez, Ángel Herrera-Gómez, Gerardo Miranda-Devora, Alejandro E. Padilla-Rosciano, Carolina Castillo-Morales, César A. Paleta-Torres, Ezequiel Vázquez-Cortes
Publikováno v:
Cirugía y Cirujanos, Vol 91, Iss 2 (2023)
Antecedentes. La incidencia de carcinomatosis peritoneal (CP) secundaria a cáncer gastrointestinal o ginecológico ha aumentado y tiene peor pronóstico en comparación con otros sitios de metástasis. El índice de carcinomatosis peritoneal (ICP) e
Externí odkaz:
https://doaj.org/article/977dff9c09fb482fabc8d0c39515e373
Autor:
Horacio N. López-Basave, Flavia Morales-Vázquez, Gerardo Miranda-Devora, Juan P. Olmos-García, Karla F. Hernández-Castañeda, Luis G. Rivera-Mogollan, Wendy R. Muñoz-Montaño
Publikováno v:
Cirugía y Cirujanos, Vol 91, Iss 6 (2023)
Antecedentes: El cáncer colorrectal (CCR) es la segunda causa de muerte por cáncer en el mundo y se estima que fue responsable de casi 935,000 muertes durante el año 2020. Objetivo: Describir las características clinicopatológicas, la superviven
Externí odkaz:
https://doaj.org/article/8d16532e26b24e07817570fc508f56a7
Autor:
Argelia Calvillo-Robledo, Enrique Pedernera, Flavia Morales-Vásquez, Delia Pérez-Montiel, María J. Gómora, Miguel Ángel Almaraz, Paulina García de Alba Graue, Elizabeth Rendón, Horacio Noé López-Basave, Andrés Quintanar-Stephano, Carmen Méndez
Publikováno v:
Journal of Ovarian Research, Vol 14, Iss 1, Pp 1-8 (2021)
Abstract Background Ovarian cancer is usually diagnosed at an advanced stage due to its early asymptomatic course and late-stage non-specific symptoms. This highlights the importance of researching the molecular mechanisms involved in ovarian carcino
Externí odkaz:
https://doaj.org/article/8890673c862d43a881fc28689a21a305
Autor:
Jeffrey C.H. Goh, Charlie Gourley, David S P Tan, Angélica Nogueira-Rodrigues, Hesham Elghazaly, Marc Edy Pierre, Gonzalo Giornelli, Byoung-Gie Kim, Flavia Morales–Vasquez, Alexandra Tyulyandina
Publikováno v:
Gynecologic Oncology Reports, Vol 42, Iss , Pp 101028- (2022)
The incidence and mortality rates of ovarian cancer are increasing globally. Ovarian cancer is diagnosed at an advanced stage in 80% of women. After standard, platinum-based, front-line chemotherapy, poly (ADP-ribose) polymerase (PARP) inhibitors and
Externí odkaz:
https://doaj.org/article/d8b61cfeb7db4d489058ed2b8eecf815
Autor:
Dolores Gallardo-Rincón, Edgar Montes-Servín, Gabriela Alamilla-García, Elizabeth Montes-Servín, Antonio Bahena-González, Lucely Cetina-Pérez, Flavia Morales Vásquez, Claudia Cano-Blanco, Jaime Coronel-Martínez, Ernesto González-Ibarra, Raquel Espinosa-Romero, Rosa María Alvarez-Gómez, Abraham Pedroza-Torres, Denisse Castro-Eguiluz
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: Ovarian cancer (OC) is gynecologic cancer with the highest mortality rate. It is estimated that 13–17% of ovarian cancers are due to heritable mutations in BRCA1 and BRCA2. The BRCA1 (BRCA1-Del ex9-12) Mexican founder mutation is respon
Externí odkaz:
https://doaj.org/article/8f8831a44578482bbad3fece7d1b1c49
Autor:
Flavia Morales-Vásquez, Rocío Castillo-Sánchez, María J. Gómora, Miguel Ángel Almaraz, Enrique Pedernera, Delia Pérez-Montiel, Elizabeth Rendón, Horacio Noé López-Basave, Edgar Román-Basaure, Sergio Cuevas-Covarrubias, Juan Maldonado-Cubas, Antonio Villa, Carmen Mendez
Publikováno v:
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-10 (2020)
Abstract Background The current study evaluated the metalloproteinases MMP-2 and MMP-9 expression in epithelial cells and the surrounding stroma in ovarian tumors and the association of MMPs with the histological subtypes, the clinical stage and the
Externí odkaz:
https://doaj.org/article/af4bcc4b28d24e92925c5c0999079769
Autor:
Enrique Pedernera, María J. Gómora, Flavia Morales-Vásquez, Delia Pérez-Montiel, Carmen Mendez
Publikováno v:
Journal of Ovarian Research, Vol 12, Iss 1, Pp 1-7 (2019)
Abstract Background Ovarian cancer is the most lethal of all gynecologic malignancies. The relationship between sexual steroids receptors and ovarian cancer progression has been largely evaluated. The presence of progesterone receptors has been assoc
Externí odkaz:
https://doaj.org/article/ecfda6d02ddc4d03b11060016b2c5620
Autor:
María J Gómora, Flavia Morales-Vásquez, Enrique Pedernera, Delia Perez-Montiel, Horacio López-Basave, Antonio R Villa, Azucena Hernández-Martínez, Esteban Mena, Carmen Mendez
Publikováno v:
Endocrine Connections, Vol 7, Iss 9, Pp 1006-1012 (2018)
The significance of the presence of androgen receptor (AR), estrogen receptor alpha (ER) and progesterone receptor (PR) in ovarian cancer patient survival has been a matter of numerous studies. This study was aimed to describe the expression profile
Externí odkaz:
https://doaj.org/article/a61416b2af764873b63d9d3c4371a29c